While gene therapy holds promise as a potential treatment for certain forms of IRDs, it is still considered experimental and may carry risks such as immune responses, off-target effects, and long-term safety concerns. Consultation with a retinal specialist is essential for evaluating individual candidacy and weighing the potential benefits and risks of gene therapy.